HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Author:

Li Bob T.ORCID,Michelini Flavia,Misale Sandra,Cocco Emiliano,Baldino Laura,Cai Yanyan,Shifman Sophie,Tu Hai-YanORCID,Myers Mackenzie L.,Xu ChongruiORCID,Mattar Marissa,Khodos Inna,Little Megan,Qeriqi Besnik,Weitsman Gregory,Wilhem Clare J.ORCID,Lalani Alshad S.,Diala Irmina,Freedman Rachel A.,Lin Nancy U.ORCID,Solit David B.,Berger Michael F.,Barber Paul R.,Ng Tony,Offin MichaelORCID,Isbell James M.,Jones David R.,Yu Helena A.,Thyparambil Sheeno,Liao Wei-Li,Bhalkikar Anuja,Cecchi Fabiola,Hyman David M.,Lewis Jason S.ORCID,Buonocore Darren J.,Ho Alan L.,Makker Vicky,Reis-Filho Jorge S.,Razavi Pedram,Arcila Maria E.,Kris Mark G.,Poirier John T.ORCID,Shen Ronglai,Tsurutani JunjiORCID,Ulaner Gary A.,de Stanchina Elisa,Rosen NealORCID,Rudin Charles M.ORCID,Scaltriti MaurizioORCID

Funder

MSK Cancer Center

NIH

Conquer Cancer Foundation

CRUK

CRUKEPSRCMRCDoHEPSRCMRCDoH

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3